{"SPADE_N_03132": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2008/0125359 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2008_0125359_A1", "Patent Type": "Patent Application", "Publication Date": "2008-5-29", "Family Info": "US7465784,US7985836,US20090156499,US20110251120", "Patent Title": "Antimicrobial peptides and methods of identifying the same.", "Abstract": "Antimicrobial peptides and methods of identifying the same are provided."}], "Sequence Information": {"SPADE ID": "SPADE_N_03132", "Peptide Name": "LL-37(17-29) (C-terminal fragment of LL-37, LL; Human, mammals, animals)", "Source": "Homo sapiens", "Family": "Belongs to truncated LL-37.", "Gene": "Not found", "Sequence": "FKRIVQRIKDFLR", "Sequence Length": 13, "UniProt Entry": ["http://www.uniprot.org/uniprot/P49913"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-", "Anticancer"], "Target Organism": "[Ref.16637646] Gram-negative bacterium:Escherichia coli K12(MIC=40 μM);Drug-resistant KBv cancer cells (LC50=60 μM), Drug-sensitive KB cancer cells (LC50=57 μM).[Ref.28178190]Gram-positive bacteria:Staphylococcus aureus ATCC 29213 (MIC=16 μM), S. faecalis ATCC 29212 (MIC=32 μM), Bacillus subtilis CMCC 63501 (MIC=16 μM), Staphylococcus epidermidis ATCC 12228 (MIC=8 μM);Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=16 μM), Escherichia coli UB 1005 (MIC=16 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μM), Pseudomonas aeruginosa PAO1 (MIC=16 μM), Salmonella typhimurium ATCC 14028 (MIC=32 μM), Salmonella typhimurium ATCC 7731 (MIC=16 μM). [Ref.23894079] Gram-positive bacteria :Staphylococcus aureus (ATCC 29213)(MIC=40 μM);Gram-negative bacteria :Escherichia coli (ATCC 25922)(MIC=5 μM)", "Hemolytic Activity": "[Ref.28161291] HC50>256 μM against human red blood cells. [Ref.23894079] MHC10=160 μM against human red blood cells", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C80H135N25O17", "Mass": 1719.08, "PI": 11.72, "Net Charge": 4, "Hydrophobicity": -0.44, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Function": "LL-37(17-29) became slightly less active than the longer ones, indicating that the truncated hydrophobic residues L31 and V32 also play a role in interaction with human cells. Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria.", "Literature": [{"Title": "Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.", "Pubmed ID": "16637646", "Reference": "J Am Chem Soc. 2006 May 3;128(17)5776-5785.", "Author": "Li X, Li Y, Han H, Miller DW, Wang G.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16637646"}, {"Title": "High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7.", "Pubmed ID": "28178190", "Reference": "Int J Mol Sci. 2017 Feb 6;18(2). pii E339.", "Author": "Tan T, Wu D, Li W, Zheng X, Li W, Shan A.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28178190"}, {"Title": "LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.", "Pubmed ID": "28161291", "Reference": "Biochim Biophys Acta Biomembr. 2017 May;1859(5)722-733.", "Author": "Rajasekaran G, Kim EY, Shin SY", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28161291"}, {"Title": "Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.", "Pubmed ID": "23894079", "Reference": "ChemMedChem. 2013 Oct;8(10)1638-42.", "Author": "Son M, Lee Y, Hwang H, Hyun S, Yu J", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=23894079"}], "Frequent Amino Acids": "RFI", "Absent Amino Acids": "ACEGHMNOPSTUWY", "Basic Residues": 5, "Acidic Residues": 1, "Hydrophobic Residues": 6, "Polar Residues": 7, "Positive Residues": 5, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02277", "Similarity": 1.0, "Sequence": "GDFFRKSKEKIGKEFKRIVQRIKDFLRN"}, {"SPADE_ID": "SPADE_N_02334", "Similarity": 1.0, "Sequence": "LLGDFFRKAREKIGEEFKRIVQRIKDFLRNLVPRTES"}, {"SPADE_ID": "SPADE_N_03100", "Similarity": 1.0, "Sequence": "KSKEKIGKEFKRIVQRIKDFLRNLVPR"}]}}}